WABCO (WBC) 10-Q 24 Oct 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 22, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'WABCO Holdings Inc.	'
Entity Central Index Key	'0001390844	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Amendment Flag	'false	'
Trading Symbol	'WBC	'
Entity Common Stock, Shares Outstanding	'	58,883,335

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Income (USD $)	3 Months Ended		9 Months Ended
In Millions, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Sales	$707.30	$677.10	$2,171.80	$2,000.10
Cost of sales	487.3	477.6	1,504.30	1,396.30
Gross Profit	220	199.5	667.5	603.8
Costs and expenses:	'	'	'	'
Selling and administrative expenses	95.7	80.6	284.7	252.3
Product engineering expenses	35.7	30.9	113.1	90.7
Other operating expenses, net	0.9	1.1	7.4	5.7
Operating income	87.7	86.9	262.3	255.1
Equity income of unconsolidated joint ventures, net	6.3	4.7	17.8	12.9
Other non-operating (expense)/income, net	0.1	-0.9	-2.7	2.8
Interest expense, net	-0.1	-0.2	0.1	-0.7
Income before income taxes	94	90.5	277.5	270.1
Income tax expense/(benefit)	9.5	8	43.3	25.8
Net Income	84.5	82.5	234.2	244.3
Less: net income attributable to noncontrolling interests	2.5	2.5	7.8	7.4
Net income attributable to Company	$82	$80	$226.40	$236.90
Net income attributable to Company per common share	'	'	'	'
Basic (in usd per share)	$1.38	$1.28	$3.75	$3.78
Diluted (in usd per share)	$1.37	$1.26	$3.71	$3.72
Cash dividends per share of common stock (in usd per share)	$0	$0	$0	$0
Weighted average common shares outstanding	'	'	'	'
Basic (in shares)	59,369,423	62,465,812	60,342,549	62,684,399
Diluted (in shares)	59,972,228	63,248,651	60,996,987	63,615,995

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$84.50	$82.50	$234.20	$244.30
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	-82.5	10.8	-85.6	-22.5
Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax	$7.40	($3)	$9.10	$0.30

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$388	$472.80
Short-term Investments	0	55.2
Accounts receivable, less allowance for doubtful accounts of $4.7 in 2013 and $3.6 in 2012	486.9	346.2
Inventories:	'	'
Finished products	101.1	93.9
Products in process	7.8	7.2
Raw materials	106.2	106.1
Future income tax benefits	12.5	10.4
Restricted cash	0	34.6
Guaranteed notes receivable	67.6	51.4
Other current assets	56.7	56.8
Total current assets	1,226.80	1,234.60
Property, plant, and equipment, less accumulated depreciation	421.7	422.5
Goodwill	437.6	381.2
Long-term future income tax benefits	223.7	248.9
Investments in unconsolidated joint ventures	19.1	19.9
Intangible assets, net	84.4	44.3
Other assets	44.8	41.4
TOTAL ASSETS	2,458.10	2,392.80
Current liabilities:	'	'
Loans payable to banks	4	40.1
Accounts payable	171.3	149.3
Accrued payroll	112.1	118.8
Current portion of warranties	27.6	29.8
Taxes payable	11.3	3.8
Accrued Liabilities, Current	55.3	58.7
Other accrued liabilities	92.8	84.9
Total current liabilities	474.4	485.4
Long-term debt	277.6	47
Post-retirement benefits	402.4	438.6
Deferred tax liabilities	129.4	120.1
Long-term income tax liabilities	47	45.3
Other liabilities	56.4	59
Total liabilities	1,387.20	1,195.40
Shareholders' equity:	'	'
Preferred stock, 4,000,000 shares authorized; none issued and outstanding	0	0
Common stock, $.01 par value, 400,000,000 shares authorized; shares issued: 77,324,703 in 2013; 75,755,306 in 2012; and shares outstanding: 62,230,330 in 2013; 62,747,151 in 2012	0.8	0.8
Capital surplus	821.6	800.2
Treasury stock, at cost: 15,094,373 shares in 2013; 13,008,155 shares in 2012	-1,198	-896.6
Retained earnings	1,598.20	1,371.80
Accumulated other comprehensive income:	'	'
Foreign currency translation adjustments	-100.1	-14.4
Unrealized losses on benefit plans, net of tax	-99.9	-109
Total shareholders' equity	1,022.60	1,152.80
Noncontrolling interests	48.3	44.6
Total equity	1,070.90	1,197.40
TOTAL LIABILITIES AND EQUITY	$2,458.10	$2,392.80

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, except Share data, unless otherwise specified
Accounts receivable, allowance for doubtful accounts	$4.20	$5
Preferred stock, shares authorized	4,000,000	4,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	77,883,857	77,471,174
Common stock, shares outstanding	58,860,790	61,359,025
Treasury stock, shares	-19,023,067	-16,112,149

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Operating activities:	'	'
Net income	$234.20	$244.30
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation	61.4	55.8
Amortization of intangibles	14.4	9
Equity in earnings of unconsolidated joint ventures, net of dividends received	0.3	0.1
Non-cash stock compensation	11.5	9.7
Deferred income tax expense	-2.2	1.6
Loss on sale or disposal of property, plant and equipment	0.2	0.2
Changes in assets and liabilities:	'	'
Accounts receivable, net	-142.2	-64.3
Inventories	-18.7	-24
Accounts payable	25.6	31.9
Other accrued liabilities and taxes	11	16.3
Other current and long-term assets	9.3	-30.9
Other long-term liabilities	6	-1.6
Net cash provided by operating activities	210.8	248.1
Investing activities:	'	'
Purchases of property, plant and equipment	-80	-58.3
Investments in capitalized software	-9.3	-9.4
Proceeds from Sale of Available-for-sale Securities	50.7	'
Payments to Acquire Available-for-sale Securities	'	0
Acquisitions, net	125.9	0
Net cash used in investing activities	-164.5	-67.7
Financing activities:	'	'
Net (repayments)/borrowings of revolving credit facilities	229	-45.9
Net repayments of short-term debt	-36.3	-7
Purchases of treasury stock	-299.5	-148.6
Dividends to noncontrolling interest holders	-4.3	-4.5
Payments to Acquire Additional Interest in Subsidiaries	-5.7	-4.6
Proceeds from exercise of stock options	12.1	44.4
Net cash used in financing activities	-104.7	-166.2
Effect of exchange rate changes on cash and cash equivalents	-26.4	-1.7
Net increase in cash and cash equivalents	-84.8	12.5
Cash and cash equivalents at beginning of period	472.8	'
Cash and cash equivalents at end of period	388	'
Cash paid during the period for:	'	'
Interest	1.3	0.2
Income taxes	30.7	30
Non cash items for the period:	'	'
Treasury stock purchase accrual	$1.90	$6.10

Basis_of_Financial_Statement_P

Basis of Financial Statement Presentation	9 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Basis of Financial Statement Presentation	'
	Basis of Financial Statement Presentation
	WABCO Holdings Inc. and its subsidiaries (collectively WABCO or the Company) develops, manufactures and sells advanced braking, stability, suspension and transmission control systems primarily for commercial vehicles. WABCO’s largest selling products are pneumatic anti-lock braking systems (ABS), electronic braking systems (EBS), automated manual transmission systems, air disc brakes and a large variety of conventional mechanical products such as actuators, air compressors and air control valves for heavy and medium-sized trucks, trailers and buses. WABCO sells its products to four groups of customers around the world: truck and bus original equipment manufacturers (OEMs), trailer OEMs, aftermarket distributors of replacement parts and services and automotive OEMs.
	The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments, including normal recurring items, considered necessary for a fair presentation of financial data have been included. The results of operations for interim periods are not necessarily indicative of the results that may be expected for the entire year. The condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying notes for the year ended December 31, 2013, included in the Company’s Annual Report on Form 10-K.
	Based on the organizational structure, as well as the nature of financial information available and reviewed by the Company’s chief operating decision maker to assess performance and make decisions about resource allocations, the Company has concluded that its total WABCO operations represent one reportable segment and that WABCO’s performance and future net cash flow perspectives are best understood and assessed as such. All majority-owned subsidiaries of WABCO are included in the consolidated financial statements and intercompany transactions are eliminated upon consolidation. WABCO’s investments in unconsolidated joint ventures are included at cost plus its equity in undistributed earnings less dividends and changes in foreign currency in accordance with the equity method of accounting and reflected as investments in unconsolidated joint ventures in the consolidated balance sheet.
	Preparation of the financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Management believes the most complex and sensitive judgments, because of their significance to the condensed consolidated financial statements, result primarily from the need to make estimates about the effects of matters that are inherently uncertain. Management’s Discussion and Analysis of Financial Condition and Results of Operations and Notes 2 and 14 to the Consolidated Financial Statements for the year ended December 31, 2013, in the Company’s Annual Report on Form 10-K, describe the most significant accounting estimates and policies used in the preparation of the Consolidated Financial Statements. Actual results in these areas could differ materially from management’s estimates. There have been no significant changes in the Company’s assumptions regarding critical accounting estimates during the first nine months of 2014.

Recently_Issued_Accounting_Sta

Recently Issued Accounting Standards	9 Months Ended
	Sep. 30, 2014
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]	'
Recently Issued Accounting Standards	'
	Recently Issued Accounting Standards
	The adoption of recently issued accounting standards did not have a material impact on the condensed consolidated financial statements, nor do we expect the pending adoption of recently issued accounting standards to have a material impact on the condensed consolidated financial statements.
	In August 2014, the FASB issued Accounting Standards Update 2014-15 (ASU 2014-15) Presentation of Financial Statements - Going Concern, which provide guidance about management's responsibility in evaluating whether there is substantial doubt relating to an entity’s ability to continue as a going concern and to provide related footnote disclosures as applicable. ASU 2014-15 is effective for the interim and annual periods ending after December 15, 2016. The Company does not expect any material impact from adoption of this guidance on the Company's condensed consolidated financial statements.
	In May 2014, the FASB issued ASU 2014-09 Revenue from Contracts with Customers, which is a new comprehensive revenue recognition standard on the financial reporting requirements for revenue from contracts entered into with customers. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2016. The Company is currently assessing the potential impact of the adoption of this guidance on its condensed consolidated financial statements.
	In July 2013, the FASB issued ASU 2013-11 Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists, which provides guidance on the presentation of unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. ASU 2013-11 is effective for interim and annual periods beginning after December 15, 2013. The Company adopted the provisions of ASU 2013-11 as of March 31, 2014, which did not affect the Company's condensed consolidated financial statements.

Comprehensive_Income

Comprehensive Income	9 Months Ended
	Sep. 30, 2014
Statement of Comprehensive Income [Abstract]	'
Comprehensive Income	'
	Comprehensive Income
	The table below presents the changes in accumulated other comprehensive loss for the three and nine month periods ended September 30, 2014 and 2013.
		Three Months						Nine Months
		Ended September 30,						Ended September 30,
	(Amount in millions)	2014			2013			2014			2013
	Foreign currency translation adjustments:
	Balance at beginning of period	(10.5		)	(37.4		)	(5.5		)	(9.5		)
	Adjustment for the period	(80.1		)	13.7			(85.1		)	(14.2		)
	Balance at end of period	(90.6		)	(23.7		)	(90.6		)	(23.7		)
	Losses on intra-entity transactions (1):
	Balance at beginning of period	(8.2		)	(7.3		)	(8.9		)	(5.9		)
	Adjustment for the period	(1.3		)	(1.5		)	(0.6		)	(2.9		)
	Balance at end of period	(9.5		)	(8.8		)	(9.5		)	(8.8		)
	Unrealized gains on investments:
	Balance at beginning of period	0.2			—			—			—
	Adjustment for the period	—			—			0.2			—
	Amounts reclassified to earnings, net	(0.2		)	—			(0.2		)	—
	Balance at end of period	—			—			—			—
	Pension and Post-retirement Plans:
	Balance at beginning of period	(107.3		)	(103.9		)	(109.0		)	(107.2		)
	Other comprehensive income before reclassifications	6.6			(4.2		)	6.2			(3.1		)
	Amounts reclassified to earnings, net (2)	0.8			1.2			2.9			3.4
	Balance at end of period	$	(99.9	)	$	(106.9	)	$	(99.9	)	$	(106.9	)
	Accumulated other comprehensive loss at end of period	$	(200.0	)	$	(139.4	)	$	(200.0	)	$	(139.4	)
	(1) Relates to intra-entity foreign currency transactions that are of a long term investment nature, when the entities to the transaction are consolidated, combined or accounted for by the equity method in the Company's financial statements.
	(2) This accumulated other comprehensive income component, net of taxes of $0.3 million and $0.5 million for the three months ended September 30, 2014 and 2013, and $1.1 million and $1.4 million for the nine months ended September 30, 2014 and 2013, is included in the computation of net periodic pension cost. See Note 13 for additional details.

Accounts_Receivable_Securitiza

Accounts Receivable Securitization Program & Financing Receivables	9 Months Ended
	Sep. 30, 2014
Accounts Receivable Financing Facility [Abstract]	'
Accounts Receivable Securitization Program & Financing Receivables	'
	Accounts Receivable Securitization Program & Financing Receivables
	On September 23, 2009, the Company established an accounts receivable securitization program (the Accounts Receivable Securitization Program) with Société Générale Bank Nederland N.V. (Société Générale) where the maximum funding from receivables that may be sold into the Accounts Receivable Securitization Program and outstanding at any point in time is €80 million. The Accounts Receivable Securitization Program expired on September 26, 2014, and was not renewed.
	During the nine months ended September 30, 2014 and prior to expiration of the Accounts Receivable Securitization Program, the Company sold all of its eligible receivables into the Accounts Receivable Securitization Program. The receivables were removed from the balance sheet in accordance with the guidance under ASC 860, Transfers and Servicing. The total amount of receivables sold under the Accounts Receivable Securitization Program for the first nine months of 2014 and 2013 were €545.7 million ($739.9 million at average exchange rates for the nine months ended September 30, 2014) and €570.9 million ($752.1 million at average exchange rates for the nine months ended September 30, 2013), respectively.
	The fair value of the receivables sold equaled the carrying cost at time of sale, and no gain or loss was recorded as a result of the sale. The Company estimated the fair value of sold receivables using Level 3 inputs and based the estimate on historical and anticipated performance of similar receivables, including historical and anticipated credit losses (if any). As part and through the expiration of the Accounts Receivable Securitization Program, the Company continued to service the receivables. The Company sold the receivables at face value, but received actual funding net of a subordinated deposit account with Société Générale until collections were received from customers for the receivables sold. The Company was exposed to the credit losses of sold receivables up to the amount of its subordinated deposit account at each settlement date. Credit losses for receivables sold and past due amounts outstanding at September 30, 2014 were both immaterial. Servicing fees paid for the program were $0.6 million for each of the nine months ended September 30, 2014 and September 30, 2013.
	In connection with the expiration of the Accounts Receivable Securitization Program, the Company entered into a separate agreement with Société Générale to repurchase accounts receivable amounting to €88.1 million ($111.7 million at September 30, 2014 exchange rates). A subordinated deposit of $38.2 million was also released to the Company, resulting in a net decrease in cash and cash equivalents of $73.5 million.
	Other receivables available for financing include receivables from reputable state owned and public enterprises in China that are settled through bankers acceptance drafts, which are registered and endorsed to the Company. These notes receivable are fully guaranteed by banks and generally have contractual maturities of six months or less, but the ultimate recourse remains against the trade debtor. These guaranteed drafts are available for discounting with banking institutions in China or transferring to suppliers to settle liabilities. The total amount of notes receivable discounted or transferred for the first nine months of 2014 and 2013 were $42.4 million and $29.6 million, respectively. There were no expenses for the nine months ended September 30, 2014 and September 30, 2013. The fair value of these guaranteed notes receivable is determined based on Level 2 inputs including credit ratings and other criteria observable in the market. The fair value of these notes equal their carrying amounts of $67.6 million and $51.4 million as of September 30, 2014 and December 31, 2013, respectively.
	The Company monitors the credit quality of both the drawers of the draft and guarantors on a monthly basis by reviewing various factors such as payment history, level of state involvement in the institution, size, national importance as well as current economic conditions in China. Since the Company has not experienced any historical losses nor is expecting future credit losses based on a review of the various credit quality indicators described above, we have not established a loss provision against these receivables as of September 30, 2014 or December 31, 2013.

Net_Income_Attributable_to_Com

Net Income Attributable to Company per Share	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Net Income Attributable to Company per Share	'
	Net Income Attributable to Company per Share
	Basic net income attributable to Company per share has been computed using the weighted average number of WABCO common shares outstanding. The average number of outstanding shares of common stock used in computing diluted net income attributable to Company per share includes weighted average incremental shares when the impact is not anti-dilutive. The weighted average incremental shares represent the net amount of shares the Company would issue upon the assumed exercise of in-the-money stock options and vesting of restricted stock units (RSUs) and deferred stock units (DSUs)after assuming that the Company would use the proceeds from the exercise of options to repurchase stock.
	Anti-dilutive shares, if applicable, are excluded and represent those options, RSUs and DSUs whose assumed proceeds were greater than the average price of the Company’s common stock.
		Three Months		Nine Months
		Ended September 30,		Ended September 30,
		2014	2013	2014	2013
	Weighted average incremental shares included	602,805	782,839	654,438	931,596
	Shares excluded due to anti-dilutive effect	—	672	—	89,304

Capital_Stock

Capital Stock	9 Months Ended
	Sep. 30, 2014
Stockholders' Equity Note [Abstract]	'
Capital Stock	'
	Capital Stock
	The following is a summary of net shares outstanding and shares issued or reacquired during the nine month period ended September 30, 2014.
		Number of Shares of Common Stock
		Total Shares	Treasury Shares		Net Shares
					Outstanding
	Balance, December 31, 2013	77,471,174	(16,112,149	)	61,359,025
	Shares issued upon exercise of stock options	319,168	—		319,168
	Shares issued upon vesting of RSUs	89,783	—		89,783
	Shares issued for DSUs	2,932	—		2,932
	Shares issued for stock awards	800	—		800
	Shares purchased for treasury	—	(2,910,918	)	(2,910,918	)
	Balance, September 30, 2014	77,883,857	(19,023,067	)	58,860,790
	The Company accounts for purchases of treasury stock under the cost method with the costs of such share purchases reflected in treasury stock in the accompanying condensed consolidated balance sheets. When treasury shares are reissued, they are recorded at the average cost of the treasury shares acquired since the inception of the share repurchase programs, net of shares previously reissued and the Company reflects the difference between the average cost paid and the amount received for the reissued shares in capital surplus. As of September 30, 2014, no shares have been reissued.
	On May 26, 2011, the Board of Directors approved the repurchase of shares in an amount not to exceed $400 million, which expired on May 31, 2013. On October 26, 2012, the Board of Directors authorized the Company to enter into an additional share repurchase program for $400 million of common shares. An additional repurchase program for $200 million of common shares was further authorized on October 29, 2013. Both of these authorizations expire on December 31, 2014.
	As of September 30, 2014, the Company has repurchased a total of $921.7 million of shares under these three repurchase programs, leaving an unexpended balance of $78.3 million available to repurchase shares in the future. Subsequent to September 30, 2014, the Company repurchased an additional 159,200 shares for a total of $14.3 million. The Company plans to continue to purchase shares at prevailing market prices. The timing and amount of share repurchases, if any, will depend on a variety of factors, including, among other things, share price, market conditions and applicable regulatory requirements.

StockBased_Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2014
Share-based Compensation [Abstract]	'
Stock-Based Compensation	'
	Stock-Based Compensation
	The Company records stock-based compensation based on the estimated fair value of the award at the grant date and recognizes that as an expense in the condensed consolidated statements of operations over the requisite service period. Commencing in 2013, the Company has replaced the stock options component of the equity incentive awards with performance stock units (PSUs), the vesting of which would occur, if at all, and at levels depending upon, the achievement of three-year cumulative earnings per share goals. The Company assesses the expected achievement levels at the end of each reporting period. As of September 30, 2014, the Company believes it is probable that the performance conditions will be met and has accrued for the compensation expense accordingly.
	Total stock-based compensation cost recognized during the three and nine month periods ended September 30, 2014 and 2013 was as follows:
		Three Months						Nine Months
		Ended September 30,						Ended September 30,
	(Amount in millions)	2014			2013			2014				2013
	Stock-based compensation	$	3.9		$	3.1		$	11.5			$	9.7
	The total number and type of awards granted during the periods presented and the related weighted-average grant-date fair values were as follows:
		Nine Months					Nine Months
		Ended September 30, 2014					Ended September 30, 2013
		Underlying		Weighted			Underlying			Weighted
		Shares		Average			Shares			Average
				Grant Date						Grant Date
				Fair Value						Fair Value
	RSUs Granted	90,201		$	100.71		110,693			$	68.13
	PSUs Granted	65,508		$	103.41		94,364			$	68.1
	DSUs Granted	6,680		$	107.88		5,864			$	75.12
	Stock Awards Granted	800		$	96.37		900			$	74.51
	Total Awards	163,189					211,821
	In the first nine months of 2014, a total of 90,201 RSUs were granted of which 78,046 vest in equal annual installments over a period of three years. Of the remaining 12,155 RSUs granted, 628 vest after two years and 11,527 vest after three years. In the first nine months of 2013, a total of 110,693 RSUs were granted of which 102,327 vest in equal annual installments over a period of three years. Of the remaining 8,366 RSUs granted, 3,120 vest after two years and 5,246 vest after three years.
	A total of 65,508 and 94,364 PSUs were granted during the first nine months of 2014 and 2013, respectively. The vesting of these PSUs would occur, if at all, and at levels depending upon, the achievement of certain three-year cumulative earnings per share goals.
	A total of 6,680 DSUs were also granted during the first nine months of 2014 compared to 5,864 DSUs granted during the first nine months of 2013. The DSUs were granted to our non-management directors as part of the equity portion of their annual retainer and were fully vested at grant. Each DSU provides the right to the issuance of a share of our common stock, within ten days after the earlier of the director’s death or disability, the 13-month anniversary of the grant date or the director’s separation from service. Each director may also elect within a month after the grant date to defer the receipt of shares for five or more years. No election can be made to accelerate the issuance of stock from a DSU.
	The Company also granted 800 stock awards in the first nine months of 2014 and 900 stock awards in the first nine months of 2013.

Debt

Debt	9 Months Ended
	Sep. 30, 2014
Long-term Debt, Unclassified [Abstract]	'
Debt	'
	Debt
	On July 8, 2011, the Company entered into a $400 million multi-currency five-year senior unsecured revolving credit facility (the "Facility") with the lenders and agent banks party thereto, including Banc of America Securities Limited as agent, issuing bank and swingline lender, and Banc of America Securities Limited, Citigroup Global Markets Limited, Fortis Bank S.A./N.V., ING Belgium SA/NV, Société Générale Corporate & Investment Banking, The Bank of Tokyo-Mitsubishi UFJ, Ltd and The Royal Bank of Scotland NV, (Belgium) Branch, as mandated lead arrangers and bookrunners and Credit Lyonnais and Unicredit Bank AG as lead arrangers. On August 23, 2013 the Company entered into an amendment agreement which extended the expiry of the Facility from September 1, 2016 to September 1, 2018. No other material terms were amended.
	As of September 30, 2014, the Facility is our principal bank credit facility, and it will expire on September 1, 2018. Under the Facility, the Company may borrow, on a revolving basis, loans in an aggregate principal amount at any one time outstanding not in excess of $400 million. Up to $50 million under the Facility may be used for issuing letters of credit, of which $49.0 million was unused as of September 30, 2014, and up to $50 million is available in the form of swingline loans, of which $50.0 million was unused as of September 30, 2014. As of September 30, 2014, the carrying amount of this facility approximated fair value based upon Level 2 inputs.
	The balance outstanding on this Facility as of September 30, 2014 was $276.0 million in addition to $1.0 million of letters of credit. The balance outstanding is classified as long-term debt as the Company does not intend to repay the balance within the next 12 months. Interest on loans under the Facility will be calculated at a rate per annum equal to an applicable margin, which can vary from 0.80% to 1.55% based on the Company's leverage ratio, plus LIBOR for loans denominated in U.S. Dollars, EURIBOR for loans denominated in Euros, HIBOR for loans denominated in Hong Kong Dollars and SIBOR for loans denominated in Singapore Dollars, plus mandatory costs, if any.
	A large portion of the proceeds of the borrowings under the Facility funds our share repurchase program. However, the proceeds will also be available to finance acquisitions, refinance existing indebtedness and meet general financing requirements.
	The Facility contains terms and provisions (including representations, covenants and conditions) customary for transactions of this type. Our primary financial covenant is a leverage test which requires net indebtedness not to exceed three times adjusted four quarter trailing EBITDA (earnings before interest, taxes, depreciation and amortization adjusted for certain items). Additional financial covenants include an interest coverage test and a maximum subsidiary indebtedness test. The interest coverage test requires three times interest expense not to exceed adjusted four quarter trailing EBITDA. The maximum subsidiary indebtedness test limits the total aggregate amount of indebtedness of WABCO's subsidiaries, excluding indebtedness under the Facility, to $400 million, of which not more than $150 million may be secured. Financial covenants, as determined on the date the Facility was signed, are not subject to any future changes in U.S. GAAP accounting standards and all cash on the balance sheet can be deducted for net indebtedness purposes. In addition, expenses and payments related to any streamlining of WABCO’s operations are excluded when calculating the four quarter trailing adjusted EBITDA. Other covenants include delivery of financial reports and other information, compliance with laws including environmental laws and permits, ERISA and U.S. regulations, limitations on liens, mergers and sales of assets and change of business.
	As of September 30, 2014 the Company had the ability to borrow an incremental $123.0 million under the Facility and was in compliance with all covenants. Various subsidiaries also had borrowings from banks totaling $5.6 million, of which $1.6 million was classified as long-term debt. The remaining $4.0 million supports local working capital requirements.

Warranties_Guarantees_Commitme

Warranties, Guarantees, Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Warranties, Guarantees, Commitments and Contingencies [Abstract]	'
Warranties, Guarantees, Commitments and Contingencies	'
	Warranties, Guarantees, Commitments and Contingencies
	Warranties
	Products sold by WABCO are covered by a basic limited warranty with terms and conditions that vary depending upon the product and country in which they were sold. The limited warranty covers the equipment, parts and labor (in certain cases) necessary to satisfy the warranty obligation generally for a period of two years. Estimated product warranty expenses are accrued in cost of goods sold at the time the related sale is recognized. Estimates of warranty expenses are based primarily on warranty claims experience and specific customer contracts. Warranty expenses include accruals for basic warranties for product sold, as well as accruals for product recalls, service campaigns and other related events when they are known and estimable. To the extent WABCO experiences changes in warranty claim activity or costs associated with servicing those claims, its warranty accrual is adjusted accordingly. Warranty accrual estimates are updated based upon the most current warranty claims information available.
	The following is a summary of changes in the Company’s product warranty liability for the three and nine month periods ended September 30, 2014 and 2013.
		Three Months						Nine Months
		Ended September 30,						Ended September 30,
	(Amount in millions)	2014			2013			2014			2013
	Balance of warranty costs accrued, beginning of period	$	52.2		$	50.3		$	51.6		$	55.2
	Warranty costs accrued	6.9			6.7			21.4			18
	Warranty claims settled	(8.0		)	(8.6		)	(21.4		)	(24.0		)
	Foreign exchange translation effects	(3.1		)	1.4			(3.6		)	0.6
	Balance of warranty costs accrued, end of period	$	48		$	49.8		$	48		$	49.8
	Current liability, included in current portion of warranties	$	27.6		$	28		$	27.6		$	28
	Long-term liability, included in other liabilities	$	20.4		$	21.8		$	20.4		$	21.8
	Warranty costs net of recoveries	$	6.9		$	5.1		$	19.2		$	14.9
	Guarantees and Commitments
	The Company has uncollateralized bank guarantees for $52.8 million, of which $47.0 million is related to tax and other litigation, $1.0 million is related to letters of credit, $0.8 million is related to performance bonds and $4.0 million is related to other items.
	Litigation
	On June 23, 2010, the European Commission (the Commission) issued a decision imposing a total of €326.1 million in fines, or approximately $400.0 million on the date of assessment (the EC Fine), on the former American Standard Companies Inc. (now Trane Inc., hereinafter referred to as American Standard or Trane), and certain of its European subsidiaries engaged in the Bath and Kitchen business and successor entities for infringements of European Union competition rules relating to the distribution of bathroom fixtures and fittings in a number of European countries. Pursuant to our Indemnification and Cooperation Agreement with Trane, WABCO Europe BVBA (an indirect wholly-owned subsidiary of WABCO) is responsible for, and is liable to indemnify Trane Inc. and Ideal Standard International (representing the successor to the Bath and Kitchen business, and owner of certain of the former American Standard subsidiaries) and their owners against the EC Fine.
	As required by the Indemnification and Cooperation Agreement, WABCO paid the fine amount into escrow on August 30, 2010, using €230.0 million of cash on hand and €96.1 million of additional borrowings. The funds were subsequently released from escrow and paid to the Commission. After reviewing all of the elements of the case, WABCO decided to appeal the decision in order to try to have the fine reduced.
	On September 16, 2013, the General Court delivered its judgment and reversed in part the decision of the Commission, reducing the original fine of €326.1 million by €205.8 million to €120.3 million.  Since WABCO had paid the full amount of the EC Fine (as described above), WABCO received the full amount of the reimbursement from the Commission in the fourth quarter of 2013.  The Commission did not appeal the judgment of the General Court within the mandatory time limit. The judgment of the General Court was thus deemed final.
	Contingencies
	We are subject to proceedings, lawsuits and other claims related to products and other matters. We are required to assess the likelihood of any adverse judgments or outcomes to these matters as well as potential ranges of probable and reasonably possible losses. A determination of the amount of liability to be recorded, if any, for these contingencies is made after careful analysis of each individual issue.
	In conjunction with the Tax Sharing Agreement, as further discussed in Note 11, WABCO is responsible for certain tax and indemnification liabilities. These liabilities include indemnification liabilities to Trane of $9.4 million as of September 30, 2014. It is reasonably possible that the Company could incur losses in excess of the amount accrued. Although this amount cannot be estimated, we believe that any additional losses would not have a material adverse impact on the condensed consolidated financial statements.

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Income Taxes
	The income tax expense was $43.3 million on pretax income of $277.5 million before adjusting for noncontrolling interest for the nine months ended September 30, 2014, and $25.8 million on pretax income of $270.1 million for the nine months ended September 30, 2013. Income tax expense is the net result of taxes on the mix of earnings in multiple tax jurisdictions, the accrual of interest on uncertain tax positions, and certain foreign tax planning. In addition, during the third quarter of 2014, the Company recognized an additional tax benefit of $2.9 million primarily related to the filing of its 2013 U.S. Federal income tax return in September 2014 and changes in the Company’s recorded tax liabilities with respect to undistributed foreign earnings. As disclosed in the 2013 Form 10-K, the Company released a valuation allowance related to management’s determination that it is more likely than not that the Company will realize its deferred tax asset in a foreign jurisdiction. The release of this valuation allowance was recorded as an income tax benefit as of December 31, 2013 which significantly reduced our effective tax rate in the year of release. As expected our effective tax rate increased following this release of the valuation allowance. Our net income and effective tax rate will continue to be negatively affected in periods following this release. However, the valuation allowance release will not affect the amount of cash paid for income taxes.
	Unrecognized tax benefits at September 30, 2014 amounted to $47.0 million predominantly related to the WABCO business, which is classified as a long-term liability. There are no material unrecognized tax benefits related to WABCO obligations directly to tax authorities for Trane’s Bath and Kitchen business as further discussed in Note 11. The Company recognizes interest and penalties accrued related to unrecognized tax benefits in income tax expense.
	The Company is subject to taxation in the United States and various state and foreign jurisdictions. With no material exceptions, the Company is no longer subject to U.S. federal, state, local or foreign examinations by tax authorities for years before 2007.

Tax_and_Indemnification_Liabil

Tax and Indemnification Liabilities Transferred from Trane to WABCO	9 Months Ended
	Sep. 30, 2014
Tax And Indemnification Liabilities [Abstract]	'
Tax and Indemnification Liabilities Transferred from Trane to WABCO	'
	Tax and Indemnification Liabilities Transferred from Trane to WABCO
	Pursuant to the Tax Sharing Agreement between Trane and WABCO, entered into on July 16, 2007, and other agreements with Trane as filed in WABCO’s Form 10 prior to its spin-off from Trane, WABCO is responsible for certain tax contingencies and indemnification liabilities. As noted in Note 10, the liabilities as of September 30, 2014 included no material amounts related to non-U.S. entities of Trane’s former Bath and Kitchen business but for which WABCO entities have obligations directly to non-U.S. tax authorities. In addition, as of September 30, 2014, the Company had indemnification liabilities of $9.4 million which are classified within long-term liabilities on the balance sheet.
	Under an indemnification agreement, WABCO Brazil is responsible for certain claims related to its business for periods prior to the spin-off of WABCO from Trane. In particular, there are tax claims pending in various stages of the Brazilian legal process related to income, social contribution and/or value added taxes for which a contingency exists and which may or may not ultimately be incurred by the Company. The estimated total amount of the contingency as of September 30, 2014 is $43.9 million including interest. However, based on management’s assessment and advice of our external legal counsel, the Company believes that it has valid arguments in all of these cases and thus no accrual is required at this time.

Streamlining_Expenses

Streamlining Expenses	9 Months Ended
	Sep. 30, 2014
Restructuring Charges [Abstract]	'
Streamlining Expenses	'
	Streamlining Expenses
	The Company accounts for employee-related streamlining charges as either a one-time benefit arrangement or an ongoing benefit arrangement as appropriate. From time to time the Company also has streamlining charges that are not related to employees, such as facility exit costs.
	Based on market declines occurring in the fourth quarter of 2008, we commenced a streamlining program on October 28, 2008 (the 2008/2009 Program), which began with a consultative process with works councils and employee representatives globally. The 2008/2009 Program reduced our global workforce by approximately 1,800 employees. This level of reduction in workforce brought our capacity in line with market demand, while still allowing us to continue our focus on core strategies, including technology, new products, globalization, and quality and productivity initiatives. We believe the completion of these actions created sufficient flexibility in production and helped us to cope with anticipated demand volatility. The Company does not expect to incur any further charges on the 2008/2009 Program.
	Based on the Company’s efforts to maintain our global footprint, the Company will periodically enter into other streamlining programs as deemed necessary (Other Programs).
	The following is a summary of changes in the Company’s streamlining program liabilities for the nine month period ended September 30, 2014. Activity for the period consisted primarily of termination payments and employee-related charges.
	(Amounts in millions)
	2008 / 2009 Program
	Balance as of December 31, 2013	$	5.9
	Charges during the first nine months of 2014	—
	Payments during the first nine months of 2014	(2.0		)
	Balance as of September 30, 2014	$	3.9
	Other Programs
	Balance as of December 31, 2013	$	19
	Charges during the first nine months of 2014	10.8
	Payments during the first nine months of 2014	(9.8		)
	Balance as of September 30, 2014	$	20
	Foreign exchange translation effects	$	(0.8	)
	Total streamlining liability as of September 30, 2014	$	23.1
	A balance of $13.7 million is classified as long term and is included in other liabilities. The remaining $9.4 million is classified as short term and is included in other accrued liabilities as of September 30, 2014.
	The following is a summary of current and cumulative streamlining costs:
		Charges for three months					Charges for nine months Ended September 30, 2014				Cumulative Charges
		Ended September 30, 2014									as of September 30, 2014
	(Amounts in millions)	2008/2009			Other		2008/2009		Other		2008/2009		Other
		Program			Programs		Program		Programs		Program		Programs
	Employee-related charges – cost of sales	$	—		$	0.3	$	—	$	5.6	$	45.7	$	22.2
	Employee-related charges – selling and administrative	—			2.9		—		5.2		45.8		25.2
	Asset write-offs	—			—		—		—		—		1.8
	Total program costs	$	—		$	3.2	$	—	$	10.8	$	91.5	$	49.2

Postretirement_Benefits

Post-retirement Benefits	9 Months Ended
	Sep. 30, 2014
General Discussion of Pension and Other Postretirement Benefits [Abstract]	'
Post-retirement Benefits	'
	Post-retirement Benefits
	Post-retirement pension, health and life insurance costs had the following components for the three and nine month periods ended September 30, 2014 and 2013:
		Three Months										Nine Months
		Ended September 30,										Ended September 30,
		2014			2014		2013			2013		2014			2014		2013			2013
	(Amounts in millions)	Pension			Health		Pension			Health		Pension			Health		Pension			Health
		Benefits			& Life		Benefits			& Life		Benefits			& Life		Benefits			& Life
					Ins.					Ins.					Ins.					Ins.
					Benefits					Benefits					Benefits					Benefits
	Service cost-benefits earned during period	$	3.2		$	—	$	3.2		$	—	$	10.6		$	0.1	$	9.6		$	—
	Interest cost on the projected benefit obligation	5			0.1		5.2			0.1		14.9			0.4		15.5			0.4
	Less: assumed return on plan assets	(2.0		)	—		(2.3		)	—		(5.9		)	—		(6.8		)	—
	Amortization of net loss	1.3			0.1		1.6			0.1		3.8			0.3		4.7			0.3
	Defined benefit plan cost	$	7.5		$	0.2	$	7.7		$	0.2	$	23.4		$	0.8	$	23		$	0.7
	The Company makes contributions to funded pension plans that, at a minimum, meet all statutory funding requirements. Contributions in 2014, as well as payments of benefits incurred by unfunded plans were in line with the expectations for 2014 and also in line with the contributions made during 2013.
	Defined benefit plan cost is included in selling and administrative expenses and cost of sales on the condensed consolidated statements of operations.

Derivative_Instruments_and_Hed

Derivative Instruments and Hedging Activities	9 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedges, Assets [Abstract]	'
Derivative Instruments and Hedging Activities	'
	Derivative Instruments and Hedging Activities
	ASC 815, Derivatives and Hedging, requires a company to recognize all of its derivative instruments as either assets or liabilities on the balance sheet at fair value. The accounting for changes in the fair value of a derivative instrument depends on whether it qualifies and has been designated as a relationship hedge. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.
	The Company recognizes all derivative financial instruments on the condensed consolidated balance sheet at fair value using Level 2 inputs and these are classified as “other current assets,” “other assets,” “other accrued liabilities” or “other liabilities” on the condensed consolidated balance sheet. Level 2 inputs used by the Company in valuing its derivative instruments include model-based valuation techniques for which all significant assumptions are observable in the market.
	The earnings impact resulting from changes in the fair value of derivative instruments is recorded in the same line item in the condensed consolidated statement of operations as the underlying exposure being hedged or in accumulated other comprehensive income for derivatives that qualify and have been designated as cash flow hedges or hedges of a net investment in a foreign operation. Any ineffective portion of a financial instrument's change in fair value is recognized in earnings together with changes in the fair value of any derivatives not designated as relationship hedges.
	Foreign exchange contracts are used by the Company to offset the earnings impact relating to the variability in exchange rates on certain assets and liabilities denominated in non-functional currencies and have not been designated as relationship hedges. As of September 30, 2014, forward contracts for an aggregate notional amount of €113.2 million ($143.6 million at September 30, 2014 exchange rates) were outstanding with an average duration of one month. These foreign exchange contracts have offset the revaluation of assets and liabilities. The combined net non-operating gain for the nine months ended September 30, 2014 was $0.2 million. The majority of these exchange contracts were entered into on September 29, 2014. The fair value of the derivatives was zero at September 30, 2014.

Business_combinations_Notes

Business combinations (Notes)	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Business Combinations	'
	Business Combinations
	On February 12, 2014, WABCO Europe BVBA (WABCO Europe), a Belgian subsidiary of the Company, entered into a stock purchase agreement (the Agreement) to purchase all of the outstanding shares of Tavares NV (Tavares), a limited liability company incorporated under the laws of Belgium, for a cash purchase price of €111.1 million ($151.0 million based on exchange rates on the acquisition date). This included the acquisition of €15.3 million of net cash held by its subsidiary Transics International NV (Transics), resulting in net consideration of €95.8 million ($130.2 million based on exchange rates on the acquisition date).
	At the date of acquisition, Tavares held 96.84% of the outstanding shares of Transics, a limited liability company incorporated under the laws of Belgium listed on NYSE Euronext Brussels. Transics develops and markets fleet management solutions to help commercial vehicle manufacturers and fleet operators to more efficiently and safely manage their trucks and trailers. The suite of innovative solutions offered by Transics helps to improve fuel efficiency and productivity while lowering operating costs.
	The allocation of the total purchase price to the assets and liabilities assumed as of the acquisition date is provisional
	as of September 30, 2014, pending receipt of a final valuation of certain intangible assets. The following table summarizes
	the preliminary allocation of the total purchase price:
	(Amounts in millions)
	Cash and cash equivalents	$	25.3
	Trade receivables	15.6
	Trade payables	(5.4		)
	Debt	(4.5		)
	Deferred tax liabilities	(13.9		)
	Property, plant and equipment	3.5
	Intangible assets	51.1
	Other assets purchased and liabilities assumed, net	(6.6		)
	Identifiable net assets acquired	$	65.1
	Goodwill	91.6
	Noncontrolling interest	(5.7		)
	Total purchase price allocation	$	151
	The intangible assets include amounts recognized for the fair value of trade name and customer-based and technology-related assets. The fair values of the intangible assets and noncontrolling interest were determined based on an income and cost approach. The intangible assets are being amortized over a weighted-average useful life of approximately 6 years, the majority of which is not deductible for tax purposes. The goodwill generated is primarily attributable to expected synergies and is not deductible for tax purposes. The transaction-related costs were expensed as incurred and are recorded within other non-operating expense.
	On April 10, 2014, in connection with the acquisition of Tavares, WABCO Europe launched a mandatory public takeover bid on all remaining shares and warrants issued by Transics in accordance with applicable Belgian takeover rules. Immediately following the initial acceptance period of the public bid, WABCO Europe launched a squeeze-out procedure that closed on May 16, 2014 for an additional payment of €4.2 million ($5.7 million based on exchange rates on the acquisition date), resulting in WABCO Europe directly and indirectly owning all shares and warrants in Transics for a total net consideration of €99.9 million ($135.9 million based on exchange rates on the acquisition date).
	The pro forma effects of this acquisition would not materially impact the Company's reported results for any period presented and as a result, no pro forma financial statements have been presented.

Noncontrolling_Interests_Notes

Noncontrolling Interests (Notes)	9 Months Ended
	Sep. 30, 2014
Noncontrolling Interest [Abstract]	'
Noncontrolling Interest Disclosure [Text Block]	'
	On May 16, 2014, a squeeze-out procedure, launched by WABCO Europe to acquire the remaining shares and warrants issued by Transics, closed. Net consideration paid as a result of the squeeze-out amounted to $5.7 million. See Note 15 for further discussion of the acquisition.
	On August 30, 2013, the Company acquired the remaining shares in its Chinese joint venture, Shandong Weiming Automotive Products (SWAP), for cash consideration of $4.6 million thus increasing its ownership from 70% to 100%. The acquisition resulted in the elimination of the noncontrolling interest and was not material to the Company's consolidated financial statements.

Comprehensive_Income_Tables

Comprehensive Income (Tables)	9 Months Ended
	Sep. 30, 2014
Statement of Comprehensive Income [Abstract]	'
Schedule of Accumulated Other Comprehensive Income (Loss)	'
	The table below presents the changes in accumulated other comprehensive loss for the three and nine month periods ended September 30, 2014 and 2013.
		Three Months						Nine Months
		Ended September 30,						Ended September 30,
	(Amount in millions)	2014			2013			2014			2013
	Foreign currency translation adjustments:
	Balance at beginning of period	(10.5		)	(37.4		)	(5.5		)	(9.5		)
	Adjustment for the period	(80.1		)	13.7			(85.1		)	(14.2		)
	Balance at end of period	(90.6		)	(23.7		)	(90.6		)	(23.7		)
	Losses on intra-entity transactions (1):
	Balance at beginning of period	(8.2		)	(7.3		)	(8.9		)	(5.9		)
	Adjustment for the period	(1.3		)	(1.5		)	(0.6		)	(2.9		)
	Balance at end of period	(9.5		)	(8.8		)	(9.5		)	(8.8		)
	Unrealized gains on investments:
	Balance at beginning of period	0.2			—			—			—
	Adjustment for the period	—			—			0.2			—
	Amounts reclassified to earnings, net	(0.2		)	—			(0.2		)	—
	Balance at end of period	—			—			—			—
	Pension and Post-retirement Plans:
	Balance at beginning of period	(107.3		)	(103.9		)	(109.0		)	(107.2		)
	Other comprehensive income before reclassifications	6.6			(4.2		)	6.2			(3.1		)
	Amounts reclassified to earnings, net (2)	0.8			1.2			2.9			3.4
	Balance at end of period	$	(99.9	)	$	(106.9	)	$	(99.9	)	$	(106.9	)
	Accumulated other comprehensive loss at end of period	$	(200.0	)	$	(139.4	)	$	(200.0	)	$	(139.4	)
	(1) Relates to intra-entity foreign currency transactions that are of a long term investment nature, when the entities to the transaction are consolidated, combined or accounted for by the equity method in the Company's financial statements.
	(2) This accumulated other comprehensive income component, net of taxes of $0.3 million and $0.5 million for the three months ended September 30, 2014 and 2013, and $1.1 million and $1.4 million for the nine months ended September 30, 2014 and 2013, is included in the computation of net periodic pension cost. See Note 13 for additional details.

Net_Income_Attributable_to_Com1

Net Income Attributable to Company per Share (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	'
		Three Months		Nine Months
		Ended September 30,		Ended September 30,
		2014	2013	2014	2013
	Weighted average incremental shares included	602,805	782,839	654,438	931,596
	Shares excluded due to anti-dilutive effect	—	672	—	89,304

Capital_Stock_Tables

Capital Stock (Tables)	9 Months Ended
	Sep. 30, 2014
Stockholders' Equity Note [Abstract]	'
Schedule of Net Shares Outstanding and Shares Issued or Reacquired	'
	The following is a summary of net shares outstanding and shares issued or reacquired during the nine month period ended September 30, 2014.
		Number of Shares of Common Stock
		Total Shares	Treasury Shares		Net Shares
					Outstanding
	Balance, December 31, 2013	77,471,174	(16,112,149	)	61,359,025
	Shares issued upon exercise of stock options	319,168	—		319,168
	Shares issued upon vesting of RSUs	89,783	—		89,783
	Shares issued for DSUs	2,932	—		2,932
	Shares issued for stock awards	800	—		800
	Shares purchased for treasury	—	(2,910,918	)	(2,910,918	)
	Balance, September 30, 2014	77,883,857	(19,023,067	)	58,860,790

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2014
Share-based Compensation [Abstract]	'
Total Stock-Based Compensation Cost Recognized During Period	'
	Total stock-based compensation cost recognized during the three and nine month periods ended September 30, 2014 and 2013 was as follows:
		Three Months						Nine Months
		Ended September 30,						Ended September 30,
	(Amount in millions)	2014			2013			2014				2013
	Stock-based compensation	$	3.9		$	3.1		$	11.5			$	9.7
Total Number and Type of Awards Granted and Related Weighted-Average Grant Date Fair Values	'
	The total number and type of awards granted during the periods presented and the related weighted-average grant-date fair values were as follows:
		Nine Months					Nine Months
		Ended September 30, 2014					Ended September 30, 2013
		Underlying		Weighted			Underlying			Weighted
		Shares		Average			Shares			Average
				Grant Date						Grant Date
				Fair Value						Fair Value
	RSUs Granted	90,201		$	100.71		110,693			$	68.13
	PSUs Granted	65,508		$	103.41		94,364			$	68.1
	DSUs Granted	6,680		$	107.88		5,864			$	75.12
	Stock Awards Granted	800		$	96.37		900			$	74.51
	Total Awards	163,189					211,821
Schedule of Weighted Average Grant Date Fair Value Calculated Under The Black-Scholes Option-Pricing Model	'

Warranties_Guarantees_Commitme1

Warranties, Guarantees, Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2014
Warranties, Guarantees, Commitments and Contingencies [Abstract]	'
Summary of Changes in the Company's Product Warranty Liability	'
	The following is a summary of changes in the Company’s product warranty liability for the three and nine month periods ended September 30, 2014 and 2013.
		Three Months						Nine Months
		Ended September 30,						Ended September 30,
	(Amount in millions)	2014			2013			2014			2013
	Balance of warranty costs accrued, beginning of period	$	52.2		$	50.3		$	51.6		$	55.2
	Warranty costs accrued	6.9			6.7			21.4			18
	Warranty claims settled	(8.0		)	(8.6		)	(21.4		)	(24.0		)
	Foreign exchange translation effects	(3.1		)	1.4			(3.6		)	0.6
	Balance of warranty costs accrued, end of period	$	48		$	49.8		$	48		$	49.8
	Current liability, included in current portion of warranties	$	27.6		$	28		$	27.6		$	28
	Long-term liability, included in other liabilities	$	20.4		$	21.8		$	20.4		$	21.8
	Warranty costs net of recoveries	$	6.9		$	5.1		$	19.2		$	14.9

Streamlining_Expenses_Tables

Streamlining Expenses (Tables)	9 Months Ended
	Sep. 30, 2014
Restructuring Charges [Abstract]	'
Schedule of Streamlining Liabilities	'
	The following is a summary of changes in the Company’s streamlining program liabilities for the nine month period ended September 30, 2014. Activity for the period consisted primarily of termination payments and employee-related charges.
	(Amounts in millions)
	2008 / 2009 Program
	Balance as of December 31, 2013	$	5.9
	Charges during the first nine months of 2014	—
	Payments during the first nine months of 2014	(2.0		)
	Balance as of September 30, 2014	$	3.9
	Other Programs
	Balance as of December 31, 2013	$	19
	Charges during the first nine months of 2014	10.8
	Payments during the first nine months of 2014	(9.8		)
	Balance as of September 30, 2014	$	20
	Foreign exchange translation effects	$	(0.8	)
	Total streamlining liability as of September 30, 2014	$	23.1
Schedule of Streamlining Cost	'
	The following is a summary of current and cumulative streamlining costs:
		Charges for three months					Charges for nine months Ended September 30, 2014				Cumulative Charges
		Ended September 30, 2014									as of September 30, 2014
	(Amounts in millions)	2008/2009			Other		2008/2009		Other		2008/2009		Other
		Program			Programs		Program		Programs		Program		Programs
	Employee-related charges – cost of sales	$	—		$	0.3	$	—	$	5.6	$	45.7	$	22.2
	Employee-related charges – selling and administrative	—			2.9		—		5.2		45.8		25.2
	Asset write-offs	—			—		—		—		—		1.8
	Total program costs	$	—		$	3.2	$	—	$	10.8	$	91.5	$	49.2

Postretirement_Benefits_Tables

Post-retirement Benefits (Tables)	9 Months Ended
	Sep. 30, 2014
General Discussion of Pension and Other Postretirement Benefits [Abstract]	'
Components of Post-retirement Pension, Health and Life Insurance Costs	'
	Post-retirement pension, health and life insurance costs had the following components for the three and nine month periods ended September 30, 2014 and 2013:
		Three Months										Nine Months
		Ended September 30,										Ended September 30,
		2014			2014		2013			2013		2014			2014		2013			2013
	(Amounts in millions)	Pension			Health		Pension			Health		Pension			Health		Pension			Health
		Benefits			& Life		Benefits			& Life		Benefits			& Life		Benefits			& Life
					Ins.					Ins.					Ins.					Ins.
					Benefits					Benefits					Benefits					Benefits
	Service cost-benefits earned during period	$	3.2		$	—	$	3.2		$	—	$	10.6		$	0.1	$	9.6		$	—
	Interest cost on the projected benefit obligation	5			0.1		5.2			0.1		14.9			0.4		15.5			0.4
	Less: assumed return on plan assets	(2.0		)	—		(2.3		)	—		(5.9		)	—		(6.8		)	—
	Amortization of net loss	1.3			0.1		1.6			0.1		3.8			0.3		4.7			0.3
	Defined benefit plan cost	$	7.5		$	0.2	$	7.7		$	0.2	$	23.4		$	0.8	$	23		$	0.7

Business_combinations_Purchase

Business combinations Purchase price allocation (Tables)	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
	(Amounts in millions)
	Cash and cash equivalents	$	25.3
	Trade receivables	15.6
	Trade payables	(5.4		)
	Debt	(4.5		)
	Deferred tax liabilities	(13.9		)
	Property, plant and equipment	3.5
	Intangible assets	51.1
	Other assets purchased and liabilities assumed, net	(6.6		)
	Identifiable net assets acquired	$	65.1
	Goodwill	91.6
	Noncontrolling interest	(5.7		)
	Total purchase price allocation	$	151

Comprehensive_Income_Details

Comprehensive Income (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Statement of Comprehensive Income [Abstract]	'	'	'	'
Net income	$84.50	$82.50	$234.20	$244.30
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	-82.5	10.8	-85.6	-22.5
Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax	7.4	-3	9.1	0.3
Less: Net income attributable to noncontrolling interests	$2.50	$2.50	$7.80	$7.40

Comprehensive_Income_Accumulat

Comprehensive Income (Accumulated Other Comprehensive Income) (Details) (USD $)

Sep. 30, 2014

Jun. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Mar. 31, 2014

Mar. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Mar. 31, 2014

Mar. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Mar. 31, 2014

Mar. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Mar. 31, 2014

Mar. 31, 2013

In Millions, unless otherwise specified

Foreign Currency Translation [Member]

Foreign Currency Translation [Member]

Foreign Currency Translation [Member]

Foreign Currency Translation [Member]

Foreign Currency Translation [Member]

Foreign Currency Translation [Member]

Losses on Intra-entity transactions [Member]

Losses on Intra-entity transactions [Member]

Losses on Intra-entity transactions [Member]

Losses on Intra-entity transactions [Member]

Losses on Intra-entity transactions [Member]

Losses on Intra-entity transactions [Member]

Accumulated Net Unrealized Investment Gain (Loss) [Member]

Accumulated Net Unrealized Investment Gain (Loss) [Member]

Accumulated Net Unrealized Investment Gain (Loss) [Member]

Accumulated Net Unrealized Investment Gain (Loss) [Member]

Accumulated Net Unrealized Investment Gain (Loss) [Member]

Accumulated Net Unrealized Investment Gain (Loss) [Member]

Unrealized Losses on Defined Benefit Plans, net of tax [Member]

Unrealized Losses on Defined Benefit Plans, net of tax [Member]

Unrealized Losses on Defined Benefit Plans, net of tax [Member]

Unrealized Losses on Defined Benefit Plans, net of tax [Member]

Unrealized Losses on Defined Benefit Plans, net of tax [Member]

Unrealized Losses on Defined Benefit Plans, net of tax [Member]

Increase (Decrease) in Accumulated Other Comprehensive Income (Loss) [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Beginning balance as of Dec 31, 2012

($200)

($139.40)

'

($23.70)

($5.50)

($9.50)

($10.50)

($37.40)

'

($8.80)

[1]

($8.90)

[1]

($5.90)

[1]

($8.20)

[1]

($7.30)

[1]

'

$0

$0

'

$0.20

$0

'

($106.90)

($109)

($107.20)

($107.30)

($103.90)

Other comprehensive income before reclassifications

'

'

-80.1

13.7

-85.1

-14.2

'

'

-1.3

[1]

-1.5

[1]

-0.6

[1]

-2.9

[1]

'

'

0

0

0.2

0

'

'

6.6

-4.2

6.2

-3.1

'

'

Amounts reclassified from accumulated other comprehensive income

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.8

[2]

1.2

[2]

2.9

[2]

3.4

[2]

'

'

Ending Balance as of September 30, 2013

-200

-139.4

-90.6

'

-90.6

'

-10.5

-37.4

-9.5

[1]

'

-9.5

[1]

'

-8.2

[1]

-7.3

[1]

0

'

0

'

0.2

0

-99.9

'

-99.9

'

-107.3

-103.9

Amounts reclassified from accumulated other comprehensive income, tax

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.30

$0.50

$1.10

$1.40

'

'

[1]

(1) Relates to intra-entity foreign currency transactions that are of a long term investment nature, when the entities to the transaction are consolidated, combined or accounted for by the equity method in the Company's financial statements.

[2]

(2) This accumulated other comprehensive income component, net of taxes of $0.3 million and $0.5 million for the three months ended SeptemberB 30, 2014 and 2013, and $1.1 million and $1.4 million for the nine months ended SeptemberB 30, 2014 and 2013, is included in the computation of net periodic pension cost. See Note 13 for additional details.

Accounts_Receivable_Securitiza1

Accounts Receivable Securitization Program & Financing Receivables (Details)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2013	Dec. 31, 2013	Sep. 23, 2009
	USD ($)	EUR (€)	USD ($)	EUR (€)	USD ($)	EUR (€)
Accounts Receivable Financing Facility [Abstract]	'	'	'	'	'	'
Maximum funding from receivables	'	'	'	'	'	€ 80
Receivables sold under securitization program	739.9	545.7	752.1	570.9	'	'
Servicing fees	0.6	'	0.6	'	'	'
Accounts Receivable Repurchased	111.7	88.1	'	'	'	'
Released subordinated deposit	38.2	'	'	'	'	'
Cash paid for securitization termination	73.5	'	'	'	'	'
Restricted cash	0	'	'	'	34.6	'
Notes receivable contractual maturity maximum	'6 months	'6 months	'	'	'	'
Notes receivable discounted or transferred	42.4	'	29.6	'	'	'
Expense from discount/transfer of notes receivable	0	'	'	'	'	'
Notes receivable	$67.60	'	'	'	$51.40	'

Net_Income_Attributable_to_Com2

Net Income Attributable to Company per Share (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Earnings Per Share [Abstract]	'	'	'	'
Weighted average incremental shares included	602,805	782,839	654,438	931,596
Shares excluded due to anti-dilutive effect	0	672	0	89,304

Capital_Stock_Schedule_of_Net_

Capital Stock (Schedule of Net Shares Outstanding and Shares Issued or Reacquired) (Details) (USD $)	0 Months Ended		1 Months Ended	9 Months Ended
In Millions, except Share data, unless otherwise specified	Oct. 26, 2013	26-May-11	Oct. 22, 2014	Sep. 30, 2014
Stockholders' Equity Note [Abstract]	'	'	'	'
Stock Repurchase Program, Authorized Amount	$200	$400	$400	'
Common Stock, Shares Outstanding [Roll Forward]	'	'	'	'
Total Shares, beginning balance	'	'	77,883,857	77,471,174
Treasury Shares, beginning balance	'	'	-19,023,067	-16,112,149
Net Shares Outstanding, beginning balance	'	'	58,860,790	61,359,025
Shares issued upon exercise of stock options	'	'	'	319,168
Stock Issued During Period, Stock Awards	'	'	'	800
Shares issued upon vesting of RSUs	'	'	'	89,783
Stock Issued During Period, Shares, Deferred Stock Award	'	'	'	2,932
Shares purchased for treasury	'	'	'	-2,910,918
Total Shares, ending balance	'	'	'	77,883,857
Treasury Shares, ending balance	'	'	'	-19,023,067
Net Shares Outstanding, ending balance	'	'	'	58,860,790

Capital_Stock_Narrative_Detail

Capital Stock (Narrative) (Details) (USD $)	0 Months Ended		1 Months Ended	9 Months Ended
In Millions, except Share data, unless otherwise specified	Oct. 26, 2013	26-May-11	Oct. 22, 2014	Sep. 30, 2014
Class of Stock [Line Items]	'	'	'	'
Stock Repurchase Program, Authorized Amount	$200	$400	$400	'
Repurchases of treasury stock	'	'	'	921.7
Unexpended amount of share repurchase authorized	'	'	'	78.3
Shares purchased for treasury	'	'	'	2,910,918
Subsequent Share Repurchase [Member]	'	'	'	'
Class of Stock [Line Items]	'	'	'	'
Repurchases of treasury stock	'	'	$14.30	'
Shares purchased for treasury	'	'	159,200	'

StockBased_Compensation_Narrat

Stock-Based Compensation (Narrative) (Details)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Restricted Stock Units [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Grants during period	90,201	110,693
Remaining grants	12,155	8,366
Performance Stock Units [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Grants during period	65,508	94,364
Cumulative earnings achievement period	'3 years	'3 years
Stock Awards [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Grants during period	800	900
Vest Ratably over Three Years [Member] | Restricted Stock Units [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Grants during period	78,046	102,327
Vesting period, years	'3 years	'3 years
Vest After Two Years [Member] | Restricted Stock Units [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Grants during period	628	3,120
Vesting period, years	'2 years	'2 years
Vest After Three Years [Member] | Restricted Stock Units [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Grants during period	11,527	5,246
Vesting period, years	'3 years	'3 years

StockBased_Compensation_Total_

Stock-Based Compensation (Total Stock-Based Compensation Cost and Total Number and Type of Awards Granted and Related-Weighted Average Grant-Date Fair Values) (Details) (USD $)	9 Months Ended
In Millions, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Stock-based compensation (in usd)	$11.50	9.7	'
Total Awards, Underlying Shares	163,189	211,821	'
Restricted Stock Units [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
RSUs Granted, Underlying Shares	90,201	110,693	'
RSUs Granted, Weighted Average Grant Date Fair Value	$100.71	'	$68.13
Performance Stock Units [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
RSUs Granted, Underlying Shares	65,508	94,364	'
RSUs Granted, Weighted Average Grant Date Fair Value	$103.41	'	$68.10
Deferred Stock Units [Domain]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
RSUs Granted, Underlying Shares	6,680	5,864	'
RSUs Granted, Weighted Average Grant Date Fair Value	$107.88	'	$75.12
Stock Awards [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
RSUs Granted, Underlying Shares	800	900	'
RSUs Granted, Weighted Average Grant Date Fair Value	$96.37	'	$74.51

Debt_Narrative_Details

Debt (Narrative) (Details) (USD $)	0 Months Ended	9 Months Ended
	Jul. 08, 2011	Sep. 30, 2014
Subsidiaries [Member]	'	'
Debt Instrument [Line Items]	'	'
Borrowings from banks	'	$5,600,000
Credit Facility Expiring in 2018 [Member]	'	'
Debt Instrument [Line Items]	'	'
Credit facility initiation date	'	8-Jul-11
Multi-currency revolving credit facility	400,000,000	400,000,000
Term Of Credit Facility	'5 years	'
Credit facility expiration date	'	1-Sep-18
Balance outstanding	'	276,000,000
Interest rate, minimum	'	0.80%
Interest rate, maximum	'	1.55%
Maximum secured indebtedness of subsidiaries	'	150,000,000
Incremental ability to borrow	'	123,000,000
Credit Facility Expiring in 2018 [Member] | Letters of Credit [Member]	'	'
Debt Instrument [Line Items]	'	'
Multi-currency revolving credit facility	'	50,000,000
Unused letters of credit	'	49,000,000
Balance outstanding	'	1,000,000
Credit Facility Expiring in 2018 [Member] | Swingline Loans [Member]	'	'
Debt Instrument [Line Items]	'	'
Multi-currency revolving credit facility	'	50,000,000
Unused letters of credit	'	50,000,000
Long-term Debt [Member] | Subsidiaries [Member]	'	'
Debt Instrument [Line Items]	'	'
Borrowings from banks	'	1,600,000
Local Working Capital Requirements [Member] | Subsidiaries [Member]	'	'
Debt Instrument [Line Items]	'	'
Borrowings from banks	'	$4,000,000

Warranties_Guarantees_Commitme2

Warranties, Guarantees, Commitments and Contingencies (Narrative) (Details)	0 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 16, 2013	Aug. 30, 2010	Sep. 30, 2014	Jun. 23, 2010	Jun. 23, 2010	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014
	EUR (€)	EUR (€)	USD ($)	USD ($)	EUR (€)	Tax Litigation Claims [Member]	Letters of Credit [Member]	Performance Guarantee [Member]	Other Items [Member]
						USD ($)	USD ($)	USD ($)	USD ($)
Guarantor Obligations [Line Items]	'	'	'	'	'	'	'	'	'
Standard warranty period	'	'	'2 years	'	'	'	'	'	'
Bank guarantees	'	'	$52.80	'	'	'	'	'	'
Uncollateralized bank guarantees	'	'	'	'	'	47	1	0.8	4
Fines	120.3	'	'	400	326.1	'	'	'	'
Reduction of Fines	205.8	'	'	'	'	'	'	'	'
Cash portion of fine indemnification payment	'	230	'	'	'	'	'	'	'
Additional borrowings to escrow	'	96.1	'	'	'	'	'	'	'
Tax indemnification liability to former affiliate	'	'	$9.40	'	'	'	'	'	'

Warranties_Guarantees_Commitme3

Warranties, Guarantees, Commitments and Contingencies (Summary of Changes in the Company's Product Warranty Liability) (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Jun. 30, 2013	Mar. 31, 2013	Jun. 30, 2012
Movement in Standard Product Warranty Accrual [Roll Forward]	'	'	'	'	'	'	'	'
Balance of warranty costs accrued, beginning of period	'	$49.80	$51.60	$55.20	'	'	$52.20	$50.30
Warranty costs accrued	6.9	6.7	21.4	18	'	'	'	'
Warranty claims settled	-8	-8.6	-21.4	-24	'	'	'	'
Foreign exchange translation effects	-3.1	1.4	-3.6	0.6	'	'	'	'
Balance of warranty costs accrued, end of period	48	'	48	'	'	'	52.2	50.3
Current liability, included in current portion of warranties	27.6	'	27.6	'	29.8	28	'	'
Long-term liability, included in other liabilities	20.4	'	20.4	'	'	21.8	'	'
Product Warranty Expense	$6.90	$5.10	$19.20	$14.90	'	'	'	'

Income_Taxes_Details

Income Taxes (Details) (USD $)	1 Months Ended	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Tax Contingency [Line Items]	'	'	'	'	'
Income tax expense (benefit)	'	$9.50	$8	$43.30	$25.80
Pretax Income	'	94	90.5	277.5	270.1
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount	2.9	'	'	'	'
Unrecognized tax benefits	$47	$47	'	$47	'

Tax_and_Indemnification_Liabil1

Tax and Indemnification Liabilities Transferred from Trane to WABCO (Details) (USD $)	Sep. 30, 2014
In Millions, unless otherwise specified
Tax and Indemnification Liabilities [Line Items]	'
Tax indemnification liability to former affiliate	$9.40
Estimated total amount of the contingency	$43.90

Streamlining_Expenses_Narrativ

Streamlining Expenses (Narrative) (Details) (USD $)	71 Months Ended	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014
	employees	Other Liabilities [Member]	Streamlining Liabilities [Member]
Restructuring Cost and Reserve [Line Items]	'	'	'
Approximate global workforce reduction due to streamlining	1,800	'	'
Streamlining liabilities	'	$13.70	$9.40

Streamlining_Expenses_Schedule

Streamlining Expenses (Schedule of Streamlining Liabilities) (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014
Restructuring Reserve [Roll Forward]	'
Foreign exchange translation effects	($0.80)
Total streamlining liability as of September 30, 2013	23.1
2008 / 2009 Program [Member]	'
Restructuring Reserve [Roll Forward]	'
Beginning balance	5.9
Charges during the first nine months of 2013	0
Payments during the first nine months of 2013	-2
Ending balance	3.9
Other Programs [Member]	'
Restructuring Reserve [Roll Forward]	'
Beginning balance	19
Charges during the first nine months of 2013	10.8
Payments during the first nine months of 2013	-9.8
Ending balance	$20

Streamlining_Expenses_Schedule1

Streamlining Expenses (Schedule of Current and Cumulative Streamlining Costs) (Details) (USD $)	3 Months Ended	9 Months Ended	71 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014
2008 / 2009 Program [Member]	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Employee related charges - cost of sales	$0	$0	$45.70
Employee related charges - selling and administrative	0	0	45.8
Asset write-offs	0	0	0
Total program costs	0	0	91.5
Other Programs [Member]	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Employee related charges - cost of sales	0.3	5.6	22.2
Employee related charges - selling and administrative	2.9	5.2	25.2
Asset write-offs	0	0	1.8
Total program costs	$3.20	$10.80	$49.20

Postretirement_Benefits_Compon

Post-retirement Benefits (Components of Post-retirement Pension, Health and Life Insurance Costs) (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Pension Benefits [Member]	'	'	'	'
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]	'	'	'	'
Service cost-benefits earned during period	$3.20	$3.20	$10.60	$9.60
Interest cost on the projected benefit obligation	5	5.2	14.9	15.5
Less assumed return on plan assets	-2	-2.3	-5.9	-6.8
Amortization of net loss	1.3	1.6	3.8	4.7
Defined benefit plan cost	7.5	7.7	23.4	23
Health and Life Insurance Benefits [Member]	'	'	'	'
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]	'	'	'	'
Service cost-benefits earned during period	0	0	0.1	0
Interest cost on the projected benefit obligation	0.1	0.1	0.4	0.4
Less assumed return on plan assets	0	0	0	0
Amortization of net loss	0.1	0.1	0.3	0.3
Defined benefit plan cost	$0.20	$0.20	$0.80	$0.70

Derivative_Instruments_and_Hed1

Derivative Instruments and Hedging Activities (Narrative) (Details)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014
	USD ($)	EUR (€)
Derivative Instruments and Hedges, Assets [Abstract]	'	'
Notional amount of derivatives	$143.60	€ 113.20
Average duration of derivatives, months	'1 month	'
Derivative instruments, recognized gains / (losses)	0.2	'
Fair value of derivatives	$0	'

Business_combinations_Details

Business combinations (Details)	0 Months Ended
In Millions, unless otherwise specified	16-May-14	16-May-14	Feb. 12, 2014	Feb. 12, 2014	Aug. 30, 2013
	USD ($)	EUR (€)	USD ($)	EUR (€)	USD ($)
Business Combinations [Abstract]	'	'	'	'	'
Other Payments to Acquire Businesses	$5.70	€ 4.20	'	'	$4.60
Business Combination, Contractual Purchase Price	'	'	151	111.1	'
Cash Acquired from Acquisition	'	'	'	15.3	'
Payments to Acquire Businesses, Net of Cash Acquired	$135.90	€ 99.90	$130.20	€ 95.80	'
Business Acquisition, Percentage of Voting Interests Acquired	'	'	96.84%	96.84%	'

Business_combinations_Schedule

Business combinations Schedule of Recognized Identified Assets (Details) (Tavares [Member], USD $)	Feb. 12, 2014
In Millions, unless otherwise specified
Tavares [Member]	'
Business Acquisition [Line Items]	'
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents	$25.30
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables	15.6
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable	-5.4
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Liabilities	-4.5
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent	-13.9
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	3.5
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	51.1
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other	-6.6
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net	65.1
Business Combination, Goodwill	91.6
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value	-5.7
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest	$151

Noncontrolling_Interests_Detai

Noncontrolling Interests (Details)	0 Months Ended
In Millions, unless otherwise specified	16-May-14	16-May-14	Aug. 30, 2013
	USD ($)	EUR (€)	USD ($)
Noncontrolling Interest [Abstract]	'	'	'
Other Payments to Acquire Businesses	$5.70	€ 4.20	$4.60